Effects of commonly used intravitreal anti‐vascular endothelial growth factor drugs on mesenchymal stem cells derived from the limbus and ciliary body
ConclusionAdministrations of high doses or repeated standard doses of intravitreal anti‐VEGF agents may affect the proliferation indexes and viabilities of CB‐MSCs and LMSCs adversely. These novel findings deserve further in vivo investigations.
Source: Clinical and Experimental Ophthalmology - Category: Opthalmology Authors: Ugur Acar, Damla Erginturk Acar, Ferda Alpaslan Pinarli, Muhammed N Demir, Emrullah Beyazyildiz, Ozdemir Ozdemir, Duygu Gulmez Sevim, Meral Tiryaki, Gungor Sobaci Tags: Original Article Source Type: research
More News: Avastin | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Statistics | Stem Cell Therapy | Stem Cells